This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,902.13 contract is for the supply of Isentress 100 mg chewable tablets, with a period of performance through November 2024.
DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical needs of military healthcare facilities. This latest award is not associated with any set-aside designation, allowing DMS to leverage its woman-owned small business status to secure direct federal contracts across various medical supply categories. As a key supplier in the federal pharmaceutical supply chain, DMS provides branded and generic prescription drugs, over-the-counter medications, biologics, and other medical consumables to the Department of Defense.
Generated 2/18/25, 1:50 PM